Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Masimo's New Solution to Reduce Opioid Withdrawal Symptoms
12:35pm, Wednesday, 01'st Jul 2020
Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.
Change your RealAge to help overcome the isolation blues
05:00am, Wednesday, 01'st Jul 2020
Q: I’m lonely and blue after three months of isolation. What can I do to regain a more connected feeling? I’m 68, I live by myself and am not working. Karen G., New York City A: You’re not alone
Cognitive Assessment and Training Market 2020-2024 | Cost-Effective Online Cognitive Assessments to Boost Growth | Technavio
12:00am, Wednesday, 01'st Jul 2020
The Global Cognitive Assessment and Training Market will grow by $ 13.56 bn during 2020-2024
Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe
02:40pm, Tuesday, 30'th Jun 2020
The uptick in Bio-Rad's (BIO) core PCR and Droplet Digital PCR product revenues is the result of robust demand due to coronavirus testing and related research.
Insurer Humana teams up with Walmart, Quest, LabCorp for COVID-19 testing
01:37pm, Tuesday, 30'th Jun 2020
U.S. health insurer Humana Inc will offer its members at-home COVID-19 test collection kits, as well as provide access to drive-through testings at the hundreds of neighborhood markets of Walmart Inc,
Luminex Expands COVID-19 Testing With New Antibody Test
01:37pm, Tuesday, 30'th Jun 2020
Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.
Quest Diagnostics Marks 10 Years of Commitment to Reducing Employee Cancer Risk as CEO Cancer Gold Standard™ Employer
12:35pm, Tuesday, 30'th Jun 2020
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its commit
Leading health and well-being company Humana Inc. (NYSE: HUM) announced a pilot home-testing program today that will enable at-home COVID-19 test coll
Quest Diagnostics : Media Statement about COVID-19 Testing | MarketScreener
09:55pm, Monday, 29'th Jun 2020Renalytix AI Looks For U.S. Public Capital In IPO Filing
04:54pm, Monday, 29'th Jun 2020
Renalytix AI has filed to raise $86 million in a U.S. IPO. The firm is developing a chronic kidney disease diagnostic system. RNLX is still in development stage
Myriad Genetics' myPath Melanoma Proved Superior Per New Study
03:27pm, Monday, 29'th Jun 2020
Myriad Genetics' (MYGN) myPath Melanoma's accuracy to classify skin lesions, termed as indeterminate by standard pathological review, validated by the latest study.
Here's Why You Should Hold on to Illumina Stock for Now
01:44pm, Monday, 29'th Jun 2020
Investors continue to be optimistic about Illumina (ILMN) backed by its focus on partnerships and robust demand for its products.
CEO Roundtable on Cancer : Celebrates Employers marking Ten-Year CEO Cancer Gold Standard™ Anniversary | MarketScreener
11:20am, Monday, 29'th Jun 2020CEO Roundtable on Cancer Celebrates Employers marking Ten-Year CEO Cancer Gold Standard™ Anniversary
11:19am, Monday, 29'th Jun 2020
The CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than seven million employees and their family members p
Guggenheim Capital LLC Sells 19,074 Shares of Quest Diagnostics Inc (NYSE:DGX)
08:06am, Sunday, 28'th Jun 2020
Guggenheim Capital LLC cut its position in Quest Diagnostics Inc (NYSE:DGX) by 16.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm
